Patients with other malignancies
Liver, kidney, or other vital organ dysfunctions
Mental or blood system diseases
Patients are allergic to the drugs in our research
Treatment program was intolerant or refused to cooperate with this study
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.